Mozambique

in page functions
[French]
Mozambique
Total population (2017) 29,537,849
Birth cohort (2017) 1,122,799
Surviving Infants (surviving to 1 year per year, 2017) 1,058,346
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 57/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 79/1000
World Bank Index, IDA (2015) 3.48
Gross Nation Income (per capita US$, 2015) 590
Co-financing group (2018) Initial self-financing
No. of districts/territories (2016) 159

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Mozambique

Type of support

Approvals

2001-2022 (US$)
(28 Mar 2018)

Commitments

2001-2022 (US$)
(28 Mar 2018)

Disbursements

2000-2018 (US$)
(28 Mar 2018)

% Disbursed

(28 Mar 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $214,164,275 $242,746,029 $208,689,054
Cash Support (CASHSUPP) $170,000 $170,000 $170,000 100%
Health system strengthening (HSS 1) $16,954,633 $26,531,387 $7,528,323 44%
HPV Demo (NVS) $56,503 $56,503 $56,503 100%
Immunisation services support (ISS) $1,665,500 $1,665,500 $1,665,500 100%
Injection Safety Devices (NVS) $1,489,500 $1,902,000 $1,569,377 105%
Injection safety support (INS) $835,881 $835,881 $835,881 100%
IPV (NVS) $7,367,626 $7,367,626 $4,270,927 58%
Measles (NVS) $1,077,756 $1,077,756 $1,077,756 100%
MR 1st dose (NVS) $721,500 $1,325,500 $731,016 101%
MR-Catch-up campaign (NVS) $8,939,612 $8,939,612 $8,939,612 100%
MR-Catch-up campaign op.costs (OPC) $7,935,500 $7,935,500 $7,879,866 99%
Penta (NVS) $45,679,360 $47,631,360 $45,306,268 99%
Pneumo (NVS) $83,576,911 $95,242,411 $93,950,834 112%
Product Switch Grant (PSG) $292,000 $292,000 $271,286 93%
Rotavirus (NVS) $15,795,174 $20,166,174 $12,829,086 81%
Tetra DTP-HepB (NVS) $16,897,320 $16,897,320 $16,897,320 100%
Vaccine Introduction Grant (VIG) $4,709,499 $4,709,499 $4,709,499 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Mozambique DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 96%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2010) 76.20%
Household survey: DTP3 coverage for female (2010) 76.10%
Household survey: Last DTP3 survey (2010) 76%
% districts achieving > 80% DTP3 coverage (2016)
% districts achieving < 50% DTP3 coverage (2016)
MCV WHO/UNICEF estimates (2016) 91%

Breakdown of support

Non-vaccine support Vaccine support
11% 89%
$23,060,355 $185,628,699

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Mozambique

21 December 2017

2017 letter

2017: responding to global challenges

Letter from Gavi's CEO, Dr Seth Berkley.

26 April 2017

Mozambique-Norway

Different places, different families, same life-saving journey: Norway Q&A on value of vaccines

After a Gavi slideshow underlines how mothers living world’s apart share the same views on childhood immunisation, Norway’s Foreign Affairs Minister and the Director-General of the Institute of Public Health talk about the value of vaccines.

25 April 2017

Different places, different families, same life-saving journey

Life in Mozambique and Norway: the importance of routine immunisation to two families.

close icon

modal window here